| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f0e67818ab2d3b97121031ecfbb559e1 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C01P2006-80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C01P2002-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C01P2002-60 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C01G28-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-285 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-285
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-36 |
| filingDate |
2016-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2018-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b4f45f27f77c947a7e3c7f431c37944
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_33cd99cb79cd1d44ef57f7041a8ba6f2 |
| publicationDate |
2018-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-101844050-B1 |
| titleOfInvention |
Pharmaceutical composition for prevention or treatment of cancer comprising polymorphic form of tetraarsenic oxide |
| abstract |
The present invention relates to a pharmaceutical composition for preventing or treating cancer comprising 99% or more of crystalline polymorph (a) (As 4 O 6 -a) of arsenic oxalate or a method for producing the same, wherein the composition of the present invention has an excellent cancer cell proliferation inhibitory effect And can be usefully used as an anticancer agent. |
| priorityDate |
2016-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |